explore -WSS

explore

author：entertainment 2025-08-23 08:52:41 - browse：54877

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： 'A game

leisure time

WSS

Senate bill would ban some hospital facility fees

FTC sues over Novant Health acquisition of two N.C. hospitals

Merck, Johnson & Johnson CEOs will testify on high drug prices

FDA panel to weigh safety of artificial wombs for preterm births

Vertex non

PBMs drew scrutiny in House hearing — and so did pharma

Wikipedia

explore

hotspot

In Memoriam: Notable people who died in 2023

Grad students accuse University of California of wage theft

Virginia high school admissions case could be legal follow

Reconstructing family trees of blood cells may help predict disease

How one medical school became remarkably diverse

Why you shouldn’t ask, “What country has the best health care?”

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Trump demands the U.S. pay no more for drugs than other countries … again

Syphilis numbers in the United States reach record heights

entertainment

Akili changes sales model for its ADHD video game treatment

What happened to the House vote on health price transparency?

Fed up with FDA, ALS advocates consider a take

Why the quest to eradicate polio has stumbled

Why you shouldn’t ask, “What country has the best health care?”

House panel takes first step toward fixing drug shortages

hotspot

leisure time

hotspot

entertainment